Skip to main content
SpringerLink
Log in

Allograft — die beste Methode? Allogene Gefäßrekonstruktion bei aortalen Protheseninfektionen

  • Chapter
Zukunftsperspektiven in der Gefäßchirurgie

  • 43 Accesses

Zusammenfassung

Die chirurgische Therapie von Protheseninfektionen ist mit einer hohen Morbidität und Mortalität vergesellschaftet. Wir untersuchten, inwieweit die Rekonstruktion mit allogenen Gefäßtransplantaten die Ergebnisse verbessern kann. Die Erfahrungen eines universitären gefäßchirurgischen Zentrums werden vorgestellt und vor dem Hintergrund der Literatur diskutiert.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 49.99
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 44.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

Literatur

  1. Szilagyi DE, Smith RF, Elliott JP, Vrandecic MP (1972) Infection in arterial reconstruction with synthetic grafts. Ann Surg 176: 321–33

    Article  PubMed  CAS  Google Scholar 

  2. Quinones-Baldrich WJ, Hernandez J J, Moore WS (1991) Long-term results following surgical management of aortic graft infection. Arch Surg 126: 507–11

    Article  PubMed  CAS  Google Scholar 

  3. Chiesa R, Astore D, Piccolo G et al. (1998) Fresh and cryopreserved arterial homografts in the treatment of prosthetic graft infections: experience of the Italian Collaborative Vascular Homograft Group. Ann Vase Surg 12: 457–62

    Article  CAS  Google Scholar 

  4. Desgranges P, Beaujan F, Brunet S et al. (1998) Cryopreserved arterial allografts used for the treatment of infected vascular grafts. Ann Vase Surg 12: 583–8

    Article  CAS  Google Scholar 

  5. Kieffer E, Sabatier J, Plissonnier D, Knosalla C (2001) Prosthetic graft infection after descending thoracic/ thoracoabdominal aortic aneurysmectomy: management with in situ arterial allografts. J Vase Surg 33: 671–8

    Article  CAS  Google Scholar 

  6. Knosalla C, Weng Y, Yankah AC, Hofmeister J, Hetzer R (1996) Using aortic allograft material to treat mycotic aneurysms of the thoracic aorta. Ann Thorac Surg 61: 1146–52

    Article  PubMed  CAS  Google Scholar 

  7. Knosalla C, Goeau-Brissonniere O, Leflon V et al. (1998) Treatment of vascular graft infection by in situ replacement with cryopreserved aortic allografts: an experimental study. J Vase Surg 27: 689–98

    Article  CAS  Google Scholar 

  8. Koskas F, Plissonnier D, Bahnini A, Ruotolo C, Kieffer E (1996) In situ arterial allografting for aortoiliac graft infection: a 6-year experience. Cardiovasc Surg 4: 495–9

    Article  PubMed  CAS  Google Scholar 

  9. Koskas F, Goeau-Brissonniere O, Nicolas MH, Bacourt F, Kieffer E (1996) Arteries from human beings are less infectible by Staphylococcus aureus than polytetrafluoroethylene in an aortic dog model. J Vase Surg 23: 472–6

    Article  CAS  Google Scholar 

  10. Koskas F, Plissonnier D, Bahnini A, Ruotolo C, Kieffer E (1997) Vascular allografts. Application to the treatment of aorto-iliac prosthetic infections with in situ revascularization. Chirurgie 122: 13–7

    Google Scholar 

  11. Ruotolo C, Plissonnier D, Bahnini A, Koskas F, Kieffer E (1997) In situ arterial allografts: a new treatment for aortic prosthetic infection. Eur J Vase Endovasc Surg 14 (suppl A): 102–7

    Article  Google Scholar 

  12. Verhelst R, Lacroix V, Vraux H et al. (2000) Use of cryopreserved arterial homografts for management of infected prosthetic grafts: a multicentric study. Ann Vase Surg 14: 602–7

    Article  CAS  Google Scholar 

  13. Bandyk DF, Esses GE (1994) Prosthetic graft infection. Surg Clin North Am 74: 571–90

    PubMed  CAS  Google Scholar 

  14. Balas P (1997) An overview of aortofemoral graft infection. Eur J Vase Endovasc Surg 14: 3–4

    Article  Google Scholar 

  15. Mingoli A, Sapienza P, di Marzo L et al. (1997) Management of abdominal aortic prosthetic graft infection requiring emergent treatment. Angiology 48: 491–5

    Article  PubMed  CAS  Google Scholar 

  16. O’Hara PJ, Hertzer NR, Beven EG, Krajewski LP (1986) Surgical management of infected abdominal aortic grafts: review of a 25-year experience. J Vase Surg 3: 725–31

    Google Scholar 

  17. Seeger JM, Pretus HA, Welborn MB, Ozaki CK, Flynn TC, Huber TS (2000) Long-term outcome after treatment of aortic graft infection with staged extra-anatomic bypass grafting and aortic graft removal. J Vase Surg 32:451–9, discussion 460–1

    Google Scholar 

  18. Bandyk DF, Berni GA, Thiele BL, Towne JB (1984) Aortofemoral graft infection due to staphylococcus epidermidis. Arch Surg 119: 102–8

    Article  PubMed  CAS  Google Scholar 

  19. Henke PK, Bergamini TM, Rose SM, Richardson JD (1998) Current options in prosthetic vascular graft infection. Am Surg 64:39-45, discussion 45–6

    Google Scholar 

  20. Bergamini TM, McCurry TM, Bernard JD et al. (1996) Antibiotic efficacy against staphylococcus epidermidis adherent to vascular grafts. J Surg Res 60: 3–6

    Article  PubMed  CAS  Google Scholar 

  21. Hayes PD, Nasim A, London NJ et al. (1999) In situ replacement of infected aortic grafts with rifampicin-bonded prostheses: the Leicester experience (1992 to 1998). J Vase Surg 30: 92–8

    Article  CAS  Google Scholar 

  22. Bandyk DF, Novotney ML, Johnson BL, Back MR, Roth SR (2001) Use of rifampin-soaked gelatin- sealed polyester grafts for in situ treatment of primary aortic and vascular prosthetic infections. J Surg Res 95: 44–9

    Article  PubMed  CAS  Google Scholar 

  23. Benvenisty AI, Tannenbaum G, Ahlborn TN et al. (1988) Control of prosthetic bacterial infection: evaluation of an easily incorporated, tightly bound, silver antibiotic PTFE graft. J Surg Res 44: 1–7

    Article  PubMed  CAS  Google Scholar 

  24. Kinney EV, Bandyk DF, Seabrook GA, Kelly HM, Towne JB (1991) Antibiotic-bonded PTFE vascular grafts: the effect of silver antibiotic on bioactivity following implantation. J Surg Res 50: 430–5

    Article  PubMed  CAS  Google Scholar 

  25. Alonso M, Segura RJ, Prada C et al. (1999) Cryopreserved arterial homografts: preliminary results in infrageniculate arterial reconstructions. Ann Vase Surgl3: 261–7

    Google Scholar 

  26. Nevelsteen A, Feryn T, Lacroix H, Suy R, Goffin Y (1998) Experience with cryopreserved arterial allografts in the treatment of prosthetic graft infections. Cardiovasc Surg 6: 378–83

    Article  PubMed  CAS  Google Scholar 

  27. Magne JL, Farah I, Roux JJ et al. (1997) Below-knee bypass using fresh arterial allografts for limb salvage: early results. Ann Vase Surg 11: 237–41

    Article  CAS  Google Scholar 

  28. Leseche G, Penna C, Bouttier S, Joubert S, Andreassian B (1997) Femorodistal bypass using cryopreserved venous allografts for limb salvage. Ann Vase Surg 11: 230–6

    Article  CAS  Google Scholar 

  29. Gournier JP, Adham M, Favre JP et al. (1993) Cryopreserved arterial homografts: preliminary study. Ann Vase Surg 7: 503–11

    Article  CAS  Google Scholar 

  30. Gournier JP, Favre JP, Gay JL, Barrai X (1995) Cryopreserved arterial allografts for limb salvage in the absence of suitable saphenous vein: two-year results in 20 cases. Ann Vase Surg 9: S7–14

    Article  Google Scholar 

  31. Bahnini A, Plissonnier D, Koskas F, Kieffer E (1996) Treatment of prostheto-digestive using arterial allograft. J Mai Vase 21: 167–70

    Google Scholar 

  32. Bahnini A, Ruotolo C, Koskas F, Kieffer E (1991) In situ fresh allograft replacement of an infected aortic prosthetic graft: eighteen months’ follow-up. J Vase Surg 14: 98–102

    Article  CAS  Google Scholar 

  33. Schmitz-Rixen T, Megerman J, Colvin RB, Williams AM, Abbott WM (1988) Immunosuppressive treatment of aortic allografts. J Vase Surg 7: 82–92

    CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Gefäßzentrum, Universitätsklinikum Köln, Deutschland

    M. Gawenda, J. Heckenkamp & Prof. Dr. med. J. Brunkwall

  2. Gefäßzentrum, Klinik und Poliklinik für Visceral- und Gefäßchirurgie, Universitätsklinikum Köln, Josef-Stelzmann-Str. 9, 50931, Köln, Deutschland

    Prof. Dr. med. J. Brunkwall

Authors
  1. M. Gawenda
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. J. Heckenkamp
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Prof. Dr. med. J. Brunkwall
    View author publications

    You can also search for this author in PubMed Google Scholar

Editor information

Editors and Affiliations

  1. Gefäßchirurgischen Klinik, Ev. Krankenhaus Mülheim, Wertgasse 30, 45466, Mülheim an der Ruhr, Deutschland

    Klaus Balzer (Chefarzt) (Chefarzt)

  2. Klinik für Allgemein-, Visceral-, Gefäß- undThoraxchirurgie, Universitätsklinikum Charité, Schumannstr. 20-21, 10117, Berlin, Deutschland

    Michael Walter (Stellvertretender Direktor) (Stellvertretender Direktor)

Rights and permissions

Reprints and permissions

Copyright information

© 2002 Steinkopff Verlag Darmstadt

About this chapter

Cite this chapter

Gawenda, M., Heckenkamp, J., Brunkwall, J. (2002). Allograft — die beste Methode? Allogene Gefäßrekonstruktion bei aortalen Protheseninfektionen. In: Balzer, K., Walter, M. (eds) Zukunftsperspektiven in der Gefäßchirurgie. Steinkopff. https://doi.org/10.1007/978-3-642-93724-8_6

Download citation

  • DOI: https://doi.org/10.1007/978-3-642-93724-8_6

  • Publisher Name: Steinkopff

  • Print ISBN: 978-3-7985-1354-9

  • Online ISBN: 978-3-642-93724-8

  • eBook Packages: Springer Book Archive

Publish with us

Policies and ethics

Search

Navigation